However, in the present study, despite some of the highest prevalences of 5 key dhfr and dhps mutations reported in Africa, TS offered strong protective efficacy against malaria, and protective efficacy was maintained throughout the 29-month observation period. This evidence concerns the gene DHPS and malaria.